Triomed Health Care Pvt Ltd.
Glimepiride (1mg) + Metformin (500mg) + Voglibose (0.2mg)
Glymipril-MV 1 Tablet ER is a combination of medicines used to treat type 2 diabetes mellitus in adults, helping to control blood sugar levels.
Tablet ER
Glymipril-MV 1 Tablet ER belongs to a category of medicines known as anti-diabetic drugs. It is a combination of medicines used to treat type 2 diabetes mellitus in adults. It helps control blood sugar levels in people with diabetes.
Take this medicine in the dose and duration as advised by your doctor. Swallow it as a whole. Do not chew, crush or break it. Glymipril-MV 1 Tablet ER is to be taken empty stomach.
No common side effects listed.
It is unsafe to consume alcohol with Glymipril-MV 1 Tablet ER.
Glymipril-MV 1 Tablet ER is probably unsafe to use during breastfeeding. Limited human data suggests that the drug may pass into the breastmilk and harm the baby.
Glymipril-MV 1 Tablet ER may be unsafe to use during pregnancy. Although there are limited studies in humans, animal studies have shown harmful effects on the developing baby. Your doctor will weigh the benefits and any potential risks before prescribing it to you. Please consult your doctor.
Glymipril-MV 1 Tablet ER is a combination of three antidiabetic medicines:
Take it with food to lower your chance of having an upset stomach. It can cause hypoglycemia (low blood sugar level) when used with other antidiabetic medicines Carry a sugar source with you for immediate relief. Your doctor may check your liver function regularly. Inform your doctor if you develop symptoms such as abdominal pain, loss of appetite, or yellowing of the eyes or skin (jaundice).
Glymipril-MV 1 Tablet ER is a combination medication that includes Glimepiride, Metformin, and Voglibose. It is used to treat type 2 diabetes mellitus (DM). This medication helps to control blood glucose levels by working together with lifestyle changes like diet and exercise. Glimepiride increases insulin release from the pancreas, Metformin reduces glucose production in the liver and enhances insulin sensitivity, while Voglibose targets postprandial glucose levels.
Common side effects include hypoglycemia (low blood sugar), nausea, diarrhea, altered taste, flatulence, stomach pain, headache, skin rash, and respiratory tract infection. In some cases, severe reactions like allergic reactions may occur.
Avoid use in patients with known allergies to the medication's components. It is also contraindicated for patients with moderate to severe kidney disease, inflammatory bowel diseases (IBD), colonic ulcers, or underlying metabolic acidosis including diabetic ketoacidosis. Please inform your doctor about any pre-existing medical conditions before taking this medication.
No, consuming alcohol with Glymipril-MV 1 Tablet ER can be unsafe. It may lead to decreased blood sugar levels (hypoglycemia) and increase the risk of lactic acidosis.
Yes, Glymipril-MV 1 Tablet ER can contribute to hypoglycemia. It's important to monitor blood sugar levels regularly and be aware of symptoms like nausea, headache, irritability, hunger, sweating, dizziness, fast heart rate, and feelings of anxiety or shakiness.
Store Glymipril-MV 1 Tablet ER in its original packaging at a controlled temperature. Keep it away from sunlight and moisture. Do not share this medication with others, as it is not intended for use by anyone else. In case of unused medication, follow local guidelines for disposal.